Boston Scientific (BSX) Up 3.2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 03/04/22
Boston Scientific Announces Cash Tender Offer for up to $2.5 Billion of Its Outstanding Debt SecuritiesPRNewsWire • 03/02/22
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX™ LAAC DevicePRNewsWire • 02/28/22
Boston Scientific to Participate in 11th Annual SVB Leerink Global Healthcare ConferencePRNewsWire • 02/14/22
Boston Scientific Corporation (BSX) CEO Mike Mahoney on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/02/22
Boston Scientific to Present New Data on Advances in Chronic Pain Care at the 2022 North American Neuromodulation Society (NANS) MeetingPRNewsWire • 01/07/22
Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2021 ResultsPRNewsWire • 01/04/22